INCR News and Press, Intercure Ltd. From 05/09/22

NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that that Alex Rabinovitch, Chief Executive Officer and Amos Cohen, Chief Financi...

Michael Auerbach, Founder and Chairman of Subversive Capital and The Parent Company, updates us on GRAMF and the growth that hasn't shown up the way we expected. InterCure and the Israeli market. His new ETF PUNK which came on the scene and shorted Meta. For further details ...

NEW YORK and TORONTO and HERZLIYA, Israel, May 03, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Alliance Glo...

InterCure press release (NASDAQ:INCR): Q4 net income loss of C$1M for the fourth quarter of 2021. Revenue of C$33M three times greater than the fourth quarter of 2020 and representing sequential growth of 29%. Adjusted EBITDA of C$9M, representing a 140% increase year-over-year, sequenti...

Another record year with continued industry leading growth and profitability supported by focused strategy and execution Revenue growth expected to continue in the first quarter and throughout 2022 Strong balance sheet with $89 million cash supporting future profitable g...

Delay in publication of the Audited Results due to immaterial technical audit matters The Company expects the Audited Results will not differ from announced preliminary results NEW YORK and TORONTO and HERZLIYA, Israel, April 05, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd ...

The Daily Hit is a recap of the day’s top business stories for the cannabis industry for April 4, 2022. On The Site California Problems This article is part of an ongoing series from the Green Market Report covering some of the biggest challenges facin...

Israeli-based cannabis company InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) also known as Canndoc reported its estimated financial and operating results for the fourth quarter and year ending December 31, 2021. InterCure reported revenue of $33 million (NIS 80 million), hi...

Fourth quarter 2021 Revenue and Adjusted EBITDA 2 of $33 million and $9 million, representing an increase of almost 200% and 140% YoY, respectively Record fiscal year 2021 revenue and Adjusted EBITDA 2 of $89 million and $23 million, representin...

InterCure (NASDAQ:INCR) reported Monday operating results for the fourth quarter with revenue of C$33M (NIS 80M), representing three times greater revenue Y/Y and 29% of sequential growth. Adjusted EBITDA is C$9M (NIS 21M), up 140% Y/Y; Adjusted EBITDA margin was 26%. Net ...